Opportunities Preloader

Please Wait.....

Report

Life Science Analytics - Company Evaluation Report, 2025

Market Report I 2025-08-01 I 154 Pages I MarketsandMarkets

The Life Science Analytics Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Life Science Analytics. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 25 Life Science Analytics Companies were categorized and recognized as the quadrant leaders.
The growth of this market is primarily fueled by the increasing pressure to reduce healthcare expenditure, the growing need for standardized data formats, and the rising adoption of advanced analytical solutions across clinical trials. Technological advancements in analytics and the expanding use of analytics in sales and marketing are also key contributors to market expansion. However, the high implementation costs associated with advanced analytical systems and ongoing concerns over data privacy are likely to restrain market growth. The dominance of this segment is largely due to the significant volume of data generated from clinical trials, patient health records, and scientific research, which has heightened the demand for descriptive analytics in the life sciences sector. These tools help organizations navigate data complexity, derive actionable insights, and make well-informed decisions. Furthermore, the increasing focus on transparency, regulatory compliance, and the need for stakeholder collaboration are accelerating the adoption of descriptive analytics, ultimately empowering researchers and improving overall industry efficiency.
The 360 Quadrant maps the Life Science Analytics companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Life Science Analytics quadrant. The top criteria for product footprint evaluation included By TYPE (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics), By COMPONENT (Services, Software), By APPLICATION (Research & Development, Commercial Analytics, Regulatory Compliance, Manufacturing & Supply Chain Optimization, Safety), and By END USER (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers, Outsourced Life Science Organizations).

Key Players
Key players in the Life Science Analytics market include major global corporations and specialized innovators such as Oracle, Merative, Sas Institute Inc., Accenture, Iqvia Inc., Cognizant, Wipro, Veradigm Llc, Optum, Inc., Microsoft, Maxisit, Exlservice Holdings, Inc., Inovalon, Citiustech Inc., Saama, Axtria, Clarivate, Thoughtsphere, Thoughtspot Inc., Salesforce, Inc., Google Llc, Amazon Web Services, Inc., Veeva Systems, Elsevier, and Komodo Health, Inc. These companies are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.





Top Three Companies Analysis

Oracle
Oracle is a leading player in the life science analytics market, primarily due to its strong customer base and expansive geographic presence across over 175 countries. The company offers a comprehensive product portfolio, focusing on cloud-based solutions that address the growing demand for more flexible and integrated data management tools. Oracle continuously enhances its offerings through strategic partnerships, such as its collaboration with DNA nexus to manage multi-omic and clinical data.

Accenture
Accenture is another key player with a significant impact on the industry, driven by its health and public service segment. Accenture employs a mix of organic growth through product innovations and inorganic growth through strategic collaborations and acquisitions. The company focuses on providing holistic analytics solutions to end-user organizations, strengthening its market position in developed regions and targeting expansion in emerging markets.

IQVIA
IQVIA stands out through its advanced analytical and technology solutions tailored for the life sciences sector. The company's focus on integrating technology with health services allows it to deliver comprehensive analytics solutions that enhance clinical trial processes and support commercial operations. IQVIA's global reach and strategic investments in cutting-edge analytics technologies place it among the foremost leaders in the industry

1 INTRODUCTION 14
1.1 MARKET DEFINITION 14
1.2 INCLUSIONS & EXCLUSIONS 14
1.3 STAKEHOLDERS 15
2 EXECUTIVE SUMMARY 16
3 MARKET OVERVIEW 20
3.1 INTRODUCTION 20
3.2 MARKET DYNAMICS 20
3.2.1 DRIVERS 21
3.2.1.1 Rising pressure to curb healthcare spending 21
3.2.1.2 Need for improved data standardization 22
3.2.1.3 Technological advancements in analytical solutions 23
3.2.1.4 Heterogeneity and complexity of big data in life sciences 24
3.2.1.5 Growing adoption of analytical solutions in clinical trials 25
3.2.1.6 Increasing R&D expenditure in pharmaceutical &
biotechnology companies 26
3.2.2 RESTRAINTS 27
3.2.2.1 High implementation costs of advanced analytical solutions 27
3.2.2.2 Data privacy concerns 27
3.2.3 OPPORTUNITIES 29
3.2.3.1 Growing focus on value-based care 29
3.2.3.2 Use of analytics in precision & personalized medicine 29
3.2.3.3 Big data analytics for R&D productivity 30
3.2.3.4 Growing adoption of cloud-based analytics 31
3.2.4 CHALLENGES 31
3.2.4.1 Issues associated with data integration 31
3.2.4.2 Shortage of skilled personnel 32
3.2.4.3 Reluctance to adopt life science analytics solutions in
emerging countries 32
3.3 INDUSTRY TRENDS 33
3.3.1 GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS 33
3.3.2 LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT 34
3.3.3 FOCUS ON REAL-TIME DATA ANALYTICS 34
3.4 TECHNOLOGY ANALYSIS 35
3.4.1 KEY TECHNOLOGIES 35
3.4.1.1 Artificial intelligence and machine learning 35
3.4.1.2 Big data analytics 35
3.4.1.3 Quantum computing 36
3.4.2 COMPLEMENTARY TECHNOLOGIES 36
3.4.2.1 Bioinformatics tools 36
3.4.2.2 Internet of Things 36
3.4.3 ADJACENT TECHNOLOGIES 37
3.4.3.1 Blockchain 37
3.5 ECOSYSTEM ANALYSIS 37
3.6 VALUE CHAIN ANALYSIS 40
3.7 PORTER'S FIVE FORCES ANALYSIS 41
3.7.1 THREAT OF NEW ENTRANTS 42
3.7.2 THREAT OF SUBSTITUTES 42
3.7.3 BARGAINING POWER OF SUPPLIERS 42
3.7.4 BARGAINING POWER OF BUYERS 43
3.7.5 INTENSITY OF COMPETITIVE RIVALRY 43
3.8 KEY CONFERENCES AND EVENTS, 2025-2026 43
3.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 44
3.10 PATENT ANALYSIS 45
3.10.1 PATENT PUBLICATION TRENDS 45
3.10.2 JURISDICTION ANALYSIS: TOP APPLICANT 45
3.10.3 MAJOR PATENTS 47
3.11 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET 48
3.11.1 TOP USE CASES & MARKET POTENTIAL 48
3.11.1.1 Key use cases 50
4 COMPETITIVE LANDSCAPE 52
4.1 OVERVIEW 52
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 52
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 53
4.3 REVENUE ANALYSIS 55
4.4 MARKET SHARE ANALYSIS 56
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 58
4.5.1 STARS 58
4.5.2 EMERGING LEADERS 58
4.5.3 PERVASIVE PLAYERS 59
4.5.4 PARTICIPANTS 59
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 60
4.5.5.1 Company footprint 60
4.5.5.2 Region footprint 61
4.5.5.3 Type footprint 62
4.5.5.4 Application footprint 63
4.5.5.5 Component footprint 64
4.5.5.6 End user footprint 65
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 66
4.6.1 PROGRESSIVE COMPANIES 66
4.6.2 RESPONSIVE COMPANIES 66
4.6.3 DYNAMIC COMPANIES 66
4.6.4 STARTING BLOCKS 66
4.6.5 COMPETITIVE BENCHMARKING 68
4.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS 70
4.8 COMPANY VALUATION AND FINANCIAL METRICS 71
4.9 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICAL VENDORS 71
4.10 COMPETITIVE SCENARIO 72
4.10.1 PRODUCT LAUNCHES & ENHANCEMENTS 72
4.10.2 DEALS 73
5 COMPANY PROFILES 76
5.1 KEY PLAYERS 76
5.1.1 ORACLE 76
5.1.1.1 Business overview 76
5.1.1.2 Products & services offered 77
5.1.1.3 Recent developments 79
5.1.1.3.1 Product launches & enhancements 79
5.1.1.3.2 Deals 79
5.1.1.4 MnM view 80
5.1.1.4.1 Key strengths 80
5.1.1.4.2 Strategic choices 81
5.1.1.4.3 Weaknesses & competitive threats 81
5.1.2 MERATIVE 82
5.1.2.1 Business overview 82
5.1.2.2 Products & services offered 82
5.1.2.3 Recent developments 83
5.1.2.3.1 Deals 83
5.1.2.3.2 Other developments 83
5.1.2.4 MnM view 83
5.1.2.4.1 Right to win 83
5.1.2.4.2 Strategic choices 83
5.1.2.4.3 Weaknesses & competitive threats 84
5.1.3 SAS INSTITUTE INC. 85
5.1.3.1 Business overview 85
5.1.3.2 Products & services offered 86
5.1.3.3 Recent developments 86
5.1.3.3.1 Product launches & enhancements 86
5.1.3.3.2 Deals 87
5.1.3.4 MnM view 88
5.1.3.4.1 Right to win 88
5.1.3.4.2 Strategic choices 88
5.1.3.4.3 Weaknesses & competitive threats 88
5.1.4 ACCENTURE 89
5.1.4.1 Business overview 89
5.1.4.2 Products offered 91
5.1.4.3 Recent developments 91
5.1.4.3.1 Product launches & enhancements 91
5.1.4.3.2 Deals 91
5.1.4.3.3 Other developments 92
5.1.4.4 MnM view 92
5.1.4.4.1 Right to win 92
5.1.4.4.2 Strategic choices 92
5.1.4.4.3 Weaknesses & competitive threats 92
5.1.5 IQVIA INC. 93
5.1.5.1 Business overview 93
5.1.5.2 Products & services offered 94
5.1.5.3 Recent developments 96
5.1.5.3.1 Product launches & enhancements 96
5.1.5.3.2 Deals 97
5.1.5.3.3 Other developments 97
5.1.5.4 MnM view 98
5.1.5.4.1 Right to win 98
5.1.5.4.2 Strategic choices 98
5.1.5.4.3 Weaknesses & competitive threats 98
5.1.6 COGNIZANT 99
5.1.6.1 Business overview 99
5.1.6.2 Products & services offered 100
5.1.6.3 Recent developments 102
5.1.6.3.1 Product launches & enhancements 102
5.1.6.3.2 Deals 102
5.1.7 WIPRO 103
5.1.7.1 Business overview 103
5.1.7.2 Products & services offered 105
5.1.7.3 Recent developments 106
5.1.7.3.1 Deals 106
5.1.8 VERADIGM LLC 107
5.1.8.1 Business overview 107
5.1.8.2 Products & services offered 108
?
5.1.8.3 Recent developments 109
5.1.8.3.1 Product launches & enhancements 109
5.1.8.4 Recent developments 109
5.1.8.4.1 Deals 109
5.1.9 OPTUM, INC. 110
5.1.9.1 Business overview 110
5.1.9.2 Products & services offered 111
5.1.10 MICROSOFT 112
5.1.10.1 Business overview 112
5.1.10.2 Products & services offered 113
5.1.10.3 Recent developments 114
5.1.10.3.1 Product launches & enhancements 114
5.1.10.3.2 Deals 114
5.1.11 MAXISIT 115
5.1.11.1 Business overview 115
5.1.11.2 Products & services offered 115
5.1.11.3 Recent developments 116
5.1.11.3.1 Product launches & enhancements 116
5.1.12 EXLSERVICE HOLDINGS, INC. 117
5.1.12.1 Business overview 117
5.1.12.2 Products & services offered 118
5.1.12.3 Recent developments 119
5.1.12.3.1 Product launches & enhancements 119
5.1.12.3.2 Deals 119
5.1.13 INOVALON 120
5.1.13.1 Business overview 120
5.1.13.2 Products & services offered 121
5.1.13.3 Recent developments 122
5.1.13.3.1 Product launches & enhancements 122
5.1.13.3.2 Deals 122
5.1.14 CITIUSTECH INC. 123
5.1.14.1 Business overview 123
5.1.14.2 Products & services offered 123
5.1.14.3 Recent developments 124
5.1.14.3.1 Product launches & enhancements 124
5.1.14.3.2 Deals 124
5.1.14.3.3 Expansions 125
5.1.15 SAAMA 126
5.1.15.1 Business overview 126
5.1.15.2 Products & services offered 126
5.1.15.3 Recent developments 127
5.1.15.3.1 Product launches & enhancements 127
5.1.15.4 Recent developments 128
5.1.15.4.1 Deals 128
5.1.15.4.2 Other developments 128
5.1.16 AXTRIA 129
5.1.16.1 Business overview 129
5.1.16.2 Products & services offered 129
5.1.16.3 Recent developments 130
5.1.16.3.1 Product launches & enhancements 130
5.1.16.3.2 Deals 130
5.1.16.3.3 Expansions 130
5.1.17 CLARIVATE 131
5.1.17.1 Business overview 131
5.1.17.2 Products & services offered 132
5.1.17.3 Recent developments 133
5.1.17.3.1 Product launches & enhancements 133
5.1.17.3.2 Deals 134
5.1.18 THOUGHTSPHERE 135
5.1.18.1 Business overview 135
5.1.18.2 Products & services offered 136
5.1.19 THOUGHTSPOT INC. 137
5.1.19.1 Business overview 137
5.1.19.2 Products & services offered 137
5.1.19.3 Recent developments 138
5.1.19.3.1 Product launches & enhancements 138
5.1.19.3.2 Deals 138
5.1.20 SALESFORCE, INC. 139
5.1.20.1 Business overview 139
5.1.20.2 Products & services offered 140
5.1.20.3 Recent developments 141
5.1.20.3.1 Product launches & enhancements 141
5.1.20.3.2 Deals 141
5.2 OTHER PLAYERS 142
5.2.1 GOOGLE LLC 142
5.2.2 AMAZON WEB SERVICES, INC. 143
5.2.3 VEEVA SYSTEMS 144
5.2.4 ELSEVIER 145
5.2.5 KOMODO HEALTH, INC. 146
?
6 APPENDIX 147
6.1 RESEARCH METHODOLOGY 147
6.1.1 RESEARCH DATA 147
6.1.1.1 Secondary data 147
6.1.1.2 Primary data 148
6.1.2 RESEARCH ASSUMPTIONS 149
6.1.3 RESEARCH LIMITATIONS 150
6.1.4 RISK ANALYSIS 150
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 151
6.3 AUTHOR DETAILS 154

TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN AI IN
TELEHEALTH & TELEMEDICINE MARKET 21
TABLE 2 PHARMACEUTICAL COMPANIES IMPACTED BY CYBER INCIDENTS, 2024 28
TABLE 3 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM 39
TABLE 4 LIFE SCIENCE ANALYTICS MARKET: PORTER'S FIVE FORCES 42
TABLE 5 LIFE SCIENCE ANALYTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS 43
TABLE 6 LIST OF PATENTS/PATENT APPLICATIONS 48
TABLE 7 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
LIFE SCIENCE ANALYTICS MARKET 53
TABLE 8 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION 57
TABLE 9 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES) 61
TABLE 10 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES) 62
TABLE 11 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES) 63
TABLE 12 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES) 64
TABLE 13 LIFE SCIENCE ANALYTICS MARKET: END USER FOOTPRINT (25 COMPANIES) 65
TABLE 14 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 68
TABLE 15 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF
KEY PLAYERS (STARTUPS/SMES) 69
TABLE 16 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 72
TABLE 17 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2022-MARCH 2025 73
TABLE 18 ORACLE: COMPANY OVERVIEW 76
TABLE 19 ORACLE: PRODUCTS & SERVICES OFFERED 77
TABLE 20 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 79
TABLE 21 ORACLE: DEALS, JANUARY 2022-MARCH 2025 79
TABLE 22 MERATIVE: COMPANY OVERVIEW 82
TABLE 23 MERATIVE: PRODUCTS & SERVICES OFFERED 82
TABLE 24 MERATIVE: DEALS, JANUARY 2022-MARCH 2025 83
TABLE 25 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025 83
TABLE 26 SAS INSTITUTE: COMPANY OVERVIEW 85
TABLE 27 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED 86
TABLE 28 SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 86
TABLE 29 SAS INSTITUTE: DEALS, JANUARY 2022-MARCH 2025 87
TABLE 30 ACCENTURE: COMPANY OVERVIEW 89
TABLE 31 ACCENTURE: PRODUCTS OFFERED 91
TABLE 32 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 91
TABLE 33 ACCENTURE: DEALS, JANUARY 2022-MARCH 2025 91
TABLE 34 ACCENTURE: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025 92
TABLE 35 IQVIA: COMPANY OVERVIEW 93
TABLE 36 IQVIA: PRODUCTS & SERVICES OFFERED 94
TABLE 37 IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 96
TABLE 38 IQVIA: DEALS, JANUARY 2022-MARCH 2025 97
TABLE 39 IQVIA: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025 97
TABLE 40 COGNIZANT: COMPANY OVERVIEW 99
TABLE 41 COGNIZANT: PRODUCTS & SERVICES OFFERED 100
TABLE 42 COGNIZANT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 102
TABLE 43 COGNIZANT: DEALS, JANUARY 2022-MARCH 2025 102
TABLE 44 WIPRO: COMPANY OVERVIEW 103
TABLE 45 WIPRO: PRODUCTS & SERVICES OFFERED 105
TABLE 46 WIPRO: DEALS, JANUARY 2022-MARCH 2025 106
TABLE 47 VERADIGM: COMPANY OVERVIEW 107
TABLE 48 VERADIGM: PRODUCTS & SERVICES OFFERED 108
TABLE 49 VERADIGM: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 109
TABLE 50 VERADIGM: DEALS, JANUARY 2022-MARCH 2025 109
TABLE 51 OPTUM: COMPANY OVERVIEW 110
TABLE 52 OPTUM: PRODUCTS & SERVICES OFFERED 111
TABLE 53 MICROSOFT: COMPANY OVERVIEW 112
TABLE 54 MICROSOFT: PRODUCTS & SERVICES OFFERED 113
TABLE 55 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 114
TABLE 56 MICROSOFT: DEALS, JANUARY 2022-MARCH 2025 114
TABLE 57 MAXISIT: COMPANY OVERVIEW 115
TABLE 58 MAXISIT: PRODUCTS & SERVICES OFFERED 115
TABLE 59 MAXISIT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 116
TABLE 60 EXLSERVICE HOLDINGS: COMPANY OVERVIEW 117
TABLE 61 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED 118
TABLE 62 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 119
TABLE 63 EXLSERVICE HOLDINGS: DEALS, JANUARY 2022-MARCH 2025 119
TABLE 64 INOVALON: COMPANY OVERVIEW 120
TABLE 65 INOVALON: PRODUCTS & SERVICES OFFERED 121
TABLE 66 INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 122
TABLE 67 INOVALON: DEALS, JANUARY 2022-MARCH 2025 122
TABLE 68 CITIUSTECH: COMPANY OVERVIEW 123
TABLE 69 CITIUSTECH: PRODUCTS & SERVICES OFFERED 123
TABLE 70 CITIUSTECH: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 124
TABLE 71 CITIUSTECH: DEALS, JANUARY 2022-MARCH 2025 124
TABLE 72 CITIUSTECH: EXPANSIONS, JANUARY 2022-MARCH 2025 125
TABLE 73 SAAMA: COMPANY OVERVIEW 126
TABLE 74 SAAMA: PRODUCTS & SERVICES OFFERED 126
TABLE 75 SAAMA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 127
TABLE 76 SAAMA: DEALS, JANUARY 2022-MARCH 2025 128
TABLE 77 SAAMA: OTHER DEVELOPMENTS, JANUARY 2022-MARCH 2025 128
TABLE 78 AXTRIA: COMPANY OVERVIEW 129
TABLE 79 AXTRIA: PRODUCTS & SERVICES OFFERED 129
TABLE 80 AXTRIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MARCH 2025 130
TABLE 81 AXTRIA: DEALS, JANUARY 2022-MARCH 2025 130
TABLE 82 AXTRIA: EXPANSIONS, JANUARY 2022-MARCH 2025 130
TABLE 83 CLARIVATE: COMPANY OVERVIEW 131
TABLE 84 CLARIVATE: PRODUCTS & SERVICES OFFERED 132
TABLE 85 CLARIVATE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 133
TABLE 86 CLARIVATE: DEALS, JANUARY 2022-MARCH 2025 134
TABLE 87 THOUGHTSPHERE: COMPANY OVERVIEW 135
TABLE 88 THOUGHTSPHERE: PRODUCTS & SERVICES OFFERED 136
TABLE 89 THOUGHTSPOT: COMPANY OVERVIEW 137
TABLE 90 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED 137
TABLE 91 THOUGHTSPOT: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 138
TABLE 92 THOUGHTSPOT: DEALS, JANUARY 2022-MARCH 2025 138
TABLE 93 SALESFORCE: COMPANY OVERVIEW 139
TABLE 94 SALESFORCE: PRODUCTS & SERVICES OFFERED 140
TABLE 95 SALESFORCE: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022-MARCH 2025 141
TABLE 96 SALESFORCE: DEALS, JANUARY 2022-MARCH 2025 141
TABLE 97 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT 150

FIGURE 1 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 16
FIGURE 2 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT,
2025 VS. 2030 (USD MILLION) 17
FIGURE 3 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 17
FIGURE 4 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 18
FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REGIONAL SNAPSHOT 19
FIGURE 6 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 20
FIGURE 7 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR) 22
FIGURE 8 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM 38
FIGURE 9 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 40
FIGURE 10 LIFE SCIENCE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS 41
FIGURE 11 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET 44
FIGURE 12 JURISDICTION ANALYSIS: TOP APPLICANTS FOR LIFE SCIENCE ANALYTICS PATENTS, JANUARY 2011-MARCH 2025 45
FIGURE 13 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS, JANUARY 2011- MARCH 2025 47
FIGURE 14 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY 49
FIGURE 15 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET, 2020-2024 56
FIGURE 16 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2024) 57
FIGURE 17 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 59
FIGURE 18 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES) 60
FIGURE 19 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 67
FIGURE 20 EV/EBITDA OF KEY VENDORS 71
FIGURE 21 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICS VENDORS 71
FIGURE 22 ORACLE: COMPANY SNAPSHOT 77
FIGURE 23 ACCENTURE: COMPANY SNAPSHOT 90
FIGURE 24 IQVIA: COMPANY SNAPSHOT 94
FIGURE 25 COGNIZANT: COMPANY SNAPSHOT 100
FIGURE 26 WIPRO: COMPANY SNAPSHOT 104
FIGURE 27 VERADIGM: COMPANY SNAPSHOT 108
FIGURE 28 UNITED HEALTH GROUP: COMPANY SNAPSHOT 110
FIGURE 29 MICROSOFT: COMPANY SNAPSHOT 113
FIGURE 30 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT 118
FIGURE 31 CLARIVATE: COMPANY SNAPSHOT 132
FIGURE 32 SALESFORCE: COMPANY SNAPSHOT 140
FIGURE 33 RESEARCH DESIGN 147
FIGURE 34 PRIMARY SOURCES 149

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE